Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the ...

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, ...

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting social life of patients. However, no effective treatment has yet ...

Evidence has grown in recent decades suggesting persistence of cognitive deficits after major depressive episodes. A new systematic review and meta-analysis not only confirms this persistent cognitive ...

Researchers assessed whether early autonomic burden is associated with incident cognitive impairment in patients with prodromal Parkinson disease.

Post-operative cognitive decline, or dysfunction (POCD), is a recognized clinical phenomenon in which patients experience lasting cognitive impairment for some time following anesthesia. Cognitive ...

Cancer-related cognitive dysfunction (CRCD) and psychosocial development in young adult cancer survivors. A phase III randomized double-blind study of prophylactic topical dapsone 5% versus ...

In the recreation room at Eskaton Village in Carmichael, Bonnie Dale, one of the residents, is trying on a virtual reality (VR) headset.

In 2023, 9.8% of Louisiana seniors over the age of 65 reported having difficulty remembering, concentrating or making ...